Identification of a Cytokine-induced Antiapoptotic Molecule Anamorsin Essential for Definitive Hematopoiesis

Journal of Experimental Medicine

Volumn 199, Issue 4, 2004, Pages 581-592

  Shibayama, Hirohiko ^a   Takai, Emi ^a   Matsumura, Itaru ^a   Kouno, Michiyoshi ^a   Morii, Eiichi ^a   Kitamura, Yukihiko ^a   Takeda, Junji ^a   Kanakura, Yuzuru ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Antiapoptosis; Cytokine signal; Definitive hematopoiesis; Expression cloning; Gene targeting

Indexed keywords

ANAMORSIN; CASPASE; CYTOKINE; GROWTH FACTOR; INHIBITOR OF APOPTOSIS PROTEIN; INTERLEUKIN 3; JANUS KINASE 2; PROTEIN BCL 2; PROTEIN BCL XL; STEM CELL FACTOR; THROMBOPOIETIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; DNA MICROARRAY; EMBRYO; ERYTHROID CELL; FETUS LIVER; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; BASE SEQUENCE; CYTOKINES; GENE DELETION; GENE EXPRESSION REGULATION; HEMATOPOIESIS; INTERLEUKIN-3; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RATS;

EID: 1242321069     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20031858     Document Type: Article

References (48)

1. Lieschke, G.J., D. Grail, G. Hodgson, D. Metcalf, E. Stanley, C. Cheers, K.J. Fowler, S. Basu, Y.F. Zhan, and A.R. Dunn. 1994. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood. 84:1737-1746.
2. Gurney, A.L., K. Carver-Moore, F.J. de Sauvage, and M.W. Moore. 1994. Thrombocytopenia in c-mpl-deficient mice. Science. 265:1445-1447.
3. Wu, H., X. Liu, R. Jaenisch, and H.F. Lodish. 1995. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell. 83:59-67.
4. Broudy, V.C. 1997. Stem cell factor and hematopoiesis. Blood. 90:1345-1364.
5. Miyajima, A., Y. Ito, and T. Kinoshita. 1999. Cytokine signaling for proliferation, survival, and death in hematopoietic cells. Int. J. Hematol. 69:137-146.
6. Talapatra, S., and C.B. Thompson. 2001. Growth factor signaling in cell survival: implications for cancer treatment. J. Pharmacol. Exp. Ther. 298:873-878.
7. Odajima, J., I. Matsumura, J. Sonoyama, H. Daino, A. Kawasaki, H. Tanaka, N. Inohara, T. Kitamura, J. Downward, K. Nakajima, et al. 2000. Full oncogenic activities of v-Src are mediated by multiple signaling pathways. J. Biol. Chem. 275:24096-24105.
8. Kinoshita, T., T. Yokota, K-i. Arai, and A. Miyajima. 1995. Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoietic cells. Oncogene. 10:2207-2212.
9. Sonoyama, J., I. Matsumura, S. Ezoe, Y. Satoh, X. Zhang, Y. Kataoka, E. Takai, M. Mizuki, T. Machii, H. Wakao, et al. 2002. Functional cooperation among Ras, STAT5, and phosphatidylinositol 3-kinase is required for full oncogenic activities of BCR/ABL in K562 cells. J. Biol. Chem. 277:8076-8082.
10. von Gise, A., P. Lorenz, C. Wellbrock, B. Hemmings, F. Berberich-Siebelt, U.R. Rapp, and J. Troppmair. 2001. Apoptosis suppression by Raf-1 and MEK1 requires MEK- and phosphatidylinositol 3-kinase-dependent signals. Mol. Cell. Biol. 21:2324-2336.
11. Datta, S.R., A. Brunet, and M.E. Greenberg. 1999. Cellular survival: a play in three Akts. Genes Dev. 13:2905-2927.
12. Bouillet, P., D. Metcalf, D.C.S. Huang, D.M. Tarlinton, T.W.H. Kay, F. Kontgen, J.M. Adams, and A. Strasser. 1999. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science. 286:1735-1738.
13. Onishi, M., T. Nosaka, K. Misawa, A.L. Mui, D. Gorman, M. McMahon, A. Miyajima, and T. Kitamura. 1998. Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol. Cell. Biol. 18:3871-3879.
14. Fujio, Y., K. Kunisada, H. Hirota, K. Yamauchi-Takihara, and T. Kishimoto. 1997. Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes. J. Clin. Invest. 99:2898-2905.
15. Socolovsky, M., A.E. Fallon, S. Wang, C. Brugnara, and H.F. Lodish. 1999. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell. 98:181-191.
16. Kieslinger, M., I. Woldman, R. Moriggl, J. Hofmann, J.C. Marine, J.N. Ihle, H. Beug, and T. Decker. 2000. Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation. Genes Dev. 14:232-244.
17. Hirano, T., K. Ishihara, and M. Hibi. 2000. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene. 19:2548-2556.
18. Devireddy, L.R., J.G. Teodoro, F.A. Richard, and M.R. Green. 2001. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science. 293:829-834.
19. Fox, C.J., P.S. Hammerman, R.M. Cinalli, S.R. Master, L.A. Chodosh, and C.B. Thompson. 2003. The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor. Genes Dev. 17:1841-1854.
20. Onishi, M., A.L. Mui, Y. Morikawa, L. Cho, S. Kinoshita, G.P. Nolan, D.M. Gorman, A. Miyajima, and T. Kitamura. 1996. Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer. Blood. 88:1399-1406.
21. Matsumura, I., T. Kitamura, H. Wakao, H. Tanaka, K. Hashimoto, C. Albanese, J. Downward, R.G. Pestell, and Y. Kanakura. 1999. Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J. 18:1367-1377.
22. Sugiyama, T., A. Furuya, T. Monkawa, M. Yamamoto-Hino, S. Satoh, K. Ohmori, A. Miyawaki, N. Hanai, K. Mikoshiba, and M. Hasegawa. 1994. Monoclonal antibodies distinctively recognizing the subtypes of inositol 1, 4, 5-trisphosphate receptor: application to the studies on inflammatory cells. FEBS Lett. 354:149-154.
23. Kina, T., K. Ikuta, E. Takayama, K. Wada, A.S. Majumdar, I.L. Weissman, and Y. Katsura. 2000. The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage. Br. J. Haematol. 109:280-287.
24. Koopman, G., C.P.M. Reutelingsperger, G.A.M. Kuijten, R.M.J. Keehnen, S.T. Pals, and M.H.J. van Oers. 1994. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 84:1415-1420.
25. Shibayama, H., N. Anzai, S.E. Braun, S. Fukuda, C. Mantel, and H.E. Broxmeyer. 1999. H-Ras is involved in the inside-out signaling pathway of interleukin-3-induced integrin activation. Blood. 93:1540-1548.
26. Kitamura, T., M. Onishi, S. Kinoshita, A. Shibuya, A. Miyajima, and G.P. Nolan. 1995. Efficient screening of retroviral cDNA expression libraries. Proc. Natl. Acad. Sci. USA. 92:9146-9150.
27. Loftus, B.J., U.J. Kim, V.P. Sneddon, F. Kalush, R. Brandon, J. Fuhrmann, T. Mason, M.L. Crosby, M. Barnstead, L. Cronin, et al. 1999. Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. Genomics. 60:295-308.
28. Dzierzak, E., A. Medvinsky, and M. de Bruijn. 1998. Qualitative and quantitative aspects of haematopoietic cell development in the mammalian embryo. Immunol. Today. 19:228-236.
29. Uehara, Y., O. Minowa, C. Mori, K. Shiota, J. Kuno, T. Noda, and N. Kitamura. 1995. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature. 373:702-705.
30. Yamauchi-Takihara, K., and T. Kishimoto. 2000. Cytokines and their receptors in cardiovascular diseases-role of gp130 signaling pathway in cardiac myocyte growth and maintenance. Int. J. Exp. Pathol. 81:1-16.
31. Husmann, I., L. Soulet, J. Gautron, I. Martelly, and D. Barritault. 1996. Growth factors in skeletal muscle regeneration. Cytokine Growth Factor Rev. 7:249-258.
32. Takakura, N., X.-L. Huang, T. Naruse, I. Hamaguchi, D.J. Dumont, G.D. Yancopoulos, and T. Suda. 1998. Critical role of the Tie2 endothelial cell receptor in the development of definitive hematopoiesis. Immunity. 9:677-686.
33. Shalaby, F., J. Ho, W.L. Stanford, K.-D. Fischer, A.C. Schuh, L. Schwartz, A. Bernstein, and J. Rossant. 1997. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell. 89:981-990.
34. Neubauer, H., A. Cumano, M. Muller, H. Wu, U. Huffstadt, and K. Pfeffer. 1998. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell. 93:397-409.
35. Tamura, K., T. Sudo, U. Senftleben, A.M. Dadak, R. Johnson, and M. Karin. 2000. Requirement for p38α in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell. 102:221-231.
36. Mucenski, M.L., K. McLain, A.B. Kier, S.H. Swerdlow, C.M. Schreiner, T.A. Miller, D.W. Pietryga, W.J. Scott, Jr., and S.S. Potter. 1991. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell. 65:677-689.
37. Pevny, L., M.C. Simon, E. Robertson, W.H. Klein, S.-F. Tsai, V. D'Agati, S.H. Orkin, and F. Costantini. 1991. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature. 349:257-260.
38. Tsai, F.-Y., G. Keller, F.C. Kuo, M. Weiss, J. Chen, M. Rosenblatt, F.W. Alt, and S.H. Orkin. 1994. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature. 371:221-226.
39. Pandolfi, P.P., M.E. Roth, A. Karis, M.W. Leonard, E. Dzierzak, F.G. Grosveld, J.D. Engel, and M.H. Lindenbaum. 1995. Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nat. Genet. 11:40-44.
40. Tsang, A.P., Y. Fujiwara, D.B. Hom, and S.H. Orkin. 1998. Failure of megakaryopoiesis and arrested erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOG. Genes Dev. 12:1176-1188.
41. Okuda, T., J. van Deursen, S.W. Hiebert, G. Grosveld, and J.R. Downing. 1996. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell. 84:321-330.
42. Shivdasani, R.A., E.L. Mayer, and S.H. Orkin. 1995. Absence of blood formation in mice lacking the T-cell leukemia oncoprotein tal-1/SCL. Nature. 373:432-434.
43. Warren, A.J., W.H. Colledge, M.B.L. Carlton, M.J. Evans, A.J.H. Smith, and T.H. Rabbitts. 1994. The oncogenic cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development. Cell. 78:45-57.
44. Sasaki, K., H. Yagi, R.T. Bronson, K. Tominaga, T. Matsunashi, K. Deguchi, Y. Tani, T. Kishimoto, and T. Komori. 1996. Absence of fetal liver hematopoiesis in mice deficient in transcriptional coativator core binding factor β. Proc. Natl. Acad. Sci. USA. 93:12359-12363.
45. Nuez, B., D. Michalovich, A. Bygrave, R. Ploemacher, and F. Grosveld. 1995. Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene. Nature. 375:316-318.
46. Motoyama, N., F. Wang, K.A. Roth, H. Sawa, K. Nakayama, K. Nakayama, I. Negishi, S. Senju, Q. Zhang, S. Fujii, et al. 1995. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science. 267:1506-1510.
47. Kawane, K., H. Fukuyama, G. Kondoh, J. Takeda, Y. Ohsawa, Y. Uchiyama, and S. Nagata. 2001. Requirement of DNaseII for definitive erythropoiesis in the mouse fetal liver. Science. 292:1546-1549.
48. Kirito, K., T. Watanabe, K. Sawada, H. Endo, K. Ozawa, and N. Komatsu. 2002. Thrombopoietin regulates Bcl-xL gene expression through Stat5 and phosphatidylinositol 3-kinase activation pathways. J. Biol. Chem. 277:8329-8337.